A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(102 sites)

Argentina

Hospital Italiano de Buenos Aires. ( Site 0203), Caba, Buenos Aires

Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205), Caba, Buenos Aires

Instituto Alexander Fleming ( Site 0202), CABA, Buenos Aires

Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0208), Caba., Buenos Aires F.D.

Sanatorio Parque ( Site 0201), Rosario, Santa Fe Province